Pilongo, Rudilyn T.
HRN: 26-64-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2025
CEFUROXIME 500MG (TAB)
03/25/2025
03/31/2025
PO
500mg
BID
Intraabdominal Post Op Wound
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes